Skip to content
Delayed ~15 min

PVLA PALVELLA THERAPEUTICS INC

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: not announced yet

What 21 analyst firms say about PALVELLA THERAPEUTICS INC: their latest ratings, price targets and how far the stock is from them. How it works

175.92 USD+19.07 (+12.16%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+27.5%to the avg target 224.29 USD+48.37 USD
Buy 16 · Hold 1 · Sell 0

17 rated views · 21 analyst/firm records · 21 firms

Latest report28 Oct 2026avg report date 19 May
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MGood · #80 in the index82
  • Russell 2000 · Safest consensus · 6MGood · #27 in the index83

Recent analyst activity · last 90 days

Our tracked history has 9 reports on PVLA from 6 analyst firms in the last 90 days (22 firms in the past year).

Comparing each firm's latest target with its previous one: 1 lowered it and 2 left it unchanged.

No firm's latest available rating differs from its previous one.

Latest observed target change: HC Wainwright lowered its target from $270.00 (set 24 Mar 2026) to $246.00 on 12 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
BTIGJeet MukherjeeBuy1 Apr 2026215.00 USD
Canaccord GenuityWhitney IjemBuy18 May 2026232.00 USD
Cantor FitzgeraldJosh SchimmerBuy15 Jun 2026210.00 USD
Chardan Capital MarketsGautam ChukkaBuy28 Oct 2026240.00 USD
Clear StreetUnnamed analystBuy5 Dec 2025200.00 USD
Clear Street LLCKaveri PohlmanBuy10 Mar 2026220.00 USD
Craig-HallumAlbert LoweBuy22 Jun 2026205.00 USD
H.C. WainwrightAndrew S. FeinBuy20 Oct 2026246.00 USD · 12 Oct 2026
JonestradingCatherine NovackBuy7 May 2026209.00 USD
Lifesci CapitalSam SlutskyBuy12 Feb 2026225.00 USD
Lucid Capital MarketsDev PrasadBuy21 May 2026241.00 USD
MizuhoGraig SuvannavejhBuy10 Sep 2026Conflicting reports · excluded
OppenheimerTrevor AllredBuy15 Dec 2025200.00 USD
Raymond JamesRyan Deschner—16 Oct 2026226.00 USD
StephensSudan LoganathanBuy21 May 2026220.00 USD
StifelAnnabel Samimy—24 Feb 2026250.00 USD
TD CowenRitu S BaralBuy15 Jun 2026267.00 USD
TruistDanielle BrillConflictConflicting reports · excluded5 Aug 2026207.00 USD
Weiss RatingsUnnamed analyst—25 Sep 2026—
William BlairAlethia YoungBuy16 Oct 2026—
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 02:55 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.